Given that EZH2-92aa expression endowed GSCs with the ability to evade NK cell cytotoxicity, we next investigated whether EZH2-92aa inhibition can enhance NK cell-induced tumour eradication in vivo. This evidence concerns the gene EZH2 and neoplasm.